Physician profile
Chrysten E Cunningham
NPI 1265435606
$1,241.43
in general payments reported to CMS, 2019-2025
19 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.29 · 2021: $523 · 2022: $155 · 2023: $144 · 2024: $281 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $545.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $262.68 | 2021 | |
| Abbvie INC. | $171.90 | 2021-2025 | Liletta |
| Myovant Sciences INC. | $163.86 | 2021-2022 | |
| Hologic Sales and Service, LLC | $103.17 | 2024-2025 | Aptima, Fetal Fibronectin Enzyme Immunoassay |
| Astellas Pharma US INC | $83.30 | 2024-2025 | Veozah |
| Evofem Biosciences, INC. | $63.04 | 2024 | |
| Aspira Women'S Health INC | $54.71 | 2021-2022 | |
| Biogen, INC. | $48.76 | 2024-2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $46.76 | 2023 | |
| Sumitomo Pharma America, INC. | $45.93 | 2023 | Myfembree |
| Daiichi Sankyo INC. | $44.24 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.18 | 2019-2021 | |
| Abbott Laboratories | $23.92 | 2025 | Aveir |
| Organon LLC | $18.96 | 2023 | Nexplanon |
| Becton, Dickinson and Company | $17.67 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $16.35 | 2022 | |
| Avion Pharmaceuticals | $14.52 | 2022 | |
| Pfizer INC. | $14.02 | 2024 | |
| Channel Medsystems, INC. | $8.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chrysten Cunningham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.